Back

Medical treatment implementation in ambulatory patients with HF: preliminary data from the nationwide BRING-UP3 HF study

18 May 2025 (14:00 - 14:45)
Organised by: Logo
Congress Presentation Part of: Diuretics and intravenous iron and more Pharmacotherapy HFA Premium Access Heart Failure 2025 Heart Failure Association (HFA)

About the speaker

Photo
Doctor Emilia D'Elia

Papa Giovanni XXIII Hospital, Bergamo (Italy)

2 More presentations in this session

Presentation thumbnail
Effects of intravenous IRON supplementation in Heart Failure with Preserved Ejection Fraction (IRON-HFpEF): a comprehensive multicenter phase 2 randomized clinical trial
Mr S. Nassiri (Amsterdam, NL)
Abstract Slides Video
Presentation thumbnail
Withdrawal of neurohumoral blockade in patients with normalized ejection fractions after cardiac resynchronization therapy: long-term follow-up of the STOP-CRT trial
Doctor M. Van Es (Genk, BE)
Abstract Slides Video

Access the full session

Session thumbnail
Diuretics and intravenous iron and more

The Event

Event poster

Heart Failure 2025

18 May 2025 14:00 CET
You may be interested in
thumbnail
Congress Presentation
Discharge medical treatment implementation in patients admitted for AHF: preliminary data from the BRING-UP3 HF study
thumbnail
Congress Presentation
Longitudinal trajectories in clinical status and cardiac remodeling across the heart failure spectrum: 12-month evidence from the BRING-UP-3 HF Study
thumbnail
Congress Presentation
Early achievement of optimal medical therapy and its impact on survival and morbidity: results from a nationwide implementation science study (BRING-UP-3 HF)

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources